CBPO  China Biologic Products Inc.

Exchange

NASDAQ

Sector

Health Care

Industry

Biotechnology: Biological Products (No Diagnostic Substances)

Market Cap.

2.57B

Vuru Grade

67.23/100

Current Price

$100.01
+0.17 (+0.17%)

Growth Price

$41.11
Overvalued by 58.89%

Stability Price

$19.14
Overvalued by 80.86%

Company Metrics

  • P/E 32.2
  • P/S 9.29
  • P/B 7.38
  • EPS 3.11
  • Cash ROIC 31.13%
  • Cash Ratio 0.67
  • Dividend 0 / 0%
  • Avg. Vol. 274,037.00
  • Shares 25.70M
  • Market Cap. 2.57B

Company Description

China Biologic Products, Inc., a biopharmaceutical company, engages in the research, development, production, and manufacture of plasma-based pharmaceutical products in the People's Republic of China. It offers Human Albumin for the treatment of shock caused by blood loss trauma or burn; raised intracranial pressure caused by hydrocephalus or trauma; oedema or ascites caused by hepatocirrhosis and... more


Download 10 Years of Financial Statements:
Income Statement   Balance Sheet   Cash Flow

News

China Biologic Products (CBPO) Showing Signs Of Perilous Reversal Today
TheStreet.com - Aug 26, 2015
China Biologic Products, Inc. engages in the research, development, manufacture, and sale of human plasma-based biopharmaceutical products to hospitals and inoculation centers in the People's Republic of China.
China Biologic Products Inc (NASDAQ:CBPO) Publicized 2nd Quarter Results
Street Report - Aug 27, 2015
[Capital Cube] China Biologic Products Inc (NASDAQ:CBPO) (TREND ANALYSIS) reports preliminary financial results for the quarter ended June 30, 2015.
Analysts Expect China Biologic Products to Announce $0.89 EPS (NASDAQ:CBPO) - Dakota Financial News
Large Outflow of Money Witnessed in China Biologic Products, Inc.
Money Flow Index - Aug 24, 2015
China Biologic Products, Inc. (NASDAQ:CBPO) surged 1.41% during the last session. The last traded price was up 1.4 points at $100.11.
Shares of China Biologic Products, Inc. (NASDAQ:CBPO) Drops by -11.28% - OTC Outlook
New Lifetime High Today: China Biologic Products (CBPO)
TheStreet.com - Aug 3, 2015
China Biologic Products, Inc. engages in the research, development, manufacture, and sale of human plasma-based biopharmaceutical products to hospitals and inoculation centers in the People's Republic of China.
Earnings of $0.86 per Share Expected for China Biologic Products, Inc. (NASDAQ ... - Markets Daily
China Biologic Products Downgraded by Zacks to Hold (CBPO) - Dakota Financial News
Equity Analysis: China Biologic Products, Inc. (NASDAQ:CBPO)
Equities Focus - Aug 27, 2015
Wall street sell-side analysts have given shares of China Biologic Products, Inc. (NASDAQ:CBPO) as price target of $122.34.
China Biologic Products, Inc. Price Target Update
News Watch International - Aug 21, 2015
China Biologic Products, Inc. (NASDAQ:CBPO): The mean short term price target for China Biologic Products, Inc. (NASDAQ:CBPO) has been established at $140.5 per share. The higher price target estimate is at $146 and the lower price target estimate is ...
Oversold Stocks To Watch: China Biologic Products Inc (NASDAQ:CBPO), Intercept ... - Street Report
Brokerage Firm Focus: China Biologic Products, Inc. (NASDAQ:CBPO) - Markets Daily
Large Inflow of Money Witnessed in China Biologic Products, Inc.
Insider Trading Report - Aug 18, 2015
The shares of China Biologic Products, Inc. (NASDAQ:CBPO) traded with a loss of -0.08 points or -0.07% in the most recent session.
China Biologic Products, Inc. Analyst Rating Update - OTC Outlook
China Biologic Products, Inc. (NASDAQ:CBPO) is Expected to Report $0.86 for Q1
Markets Daily - Jul 27, 2015
According to analysts, China Biologic Products, Inc. (NASDAQ:CBPO) is expected to report earnings per share for the current fiscal quarter of $0.86.
Company Shares of China Biologic Products, Inc. Drops by -1.13% - American Trade Journal
Market Movers: China Biologic Products, Inc. (NASDAQ:CBPO), Sprint Corporation ... - Stock Transcript
Investor Insights on China Biologic Products Inc (NASDAQ:CBPO)
Markets Wired - Jul 28, 2015
[PRNewswire] China Biologic Products Inc (NASDAQ:CBPO)(TREND ANALYSIS) a leading fully integrated plasma-based biopharmaceutical company in China, today announced that the Company plans to release its second quarter 2015 financial results on ...
Mid-Day Changers: China Biologic Products, Inc. (CBPO), Bellicum ... - WallStreet Scope
Shares of China Biologic Products, Inc. (NASDAQ:CBPO) Drops by -2.25%
Insider Trading Report - Aug 10, 2015
China Biologic Products, Inc. (NASDAQ:CBPO) has dropped 2.25% during the past week, however, the bigger picture is still very bullish; the shares have posted positive gains of 7.73% in the last 4 weeks.
Analyst Rating Update: China Biologic Products, Inc. (NASDAQ:CBPO) - Markets Daily